Well.. The U.S. Food and Drug Administration (FDA
Post# of 148050
Quote:
The U.S. Food and Drug Administration (FDA) has not issued emergency use authorization for Leronlimab just yet. It is expected that this drug will soon receive authorization permits for the use of the drug only for severely ill COVID-19 patients who are already in the hospital. In other words, these drugs are being used as a last resort if a patient’s health is rapidly deteriorating.
Sounds like something your average penny stock investor would say. Maybe his staffers are.. possibly not holders of degrees in Communications.